mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.007 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.007 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.009 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.009 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.009 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |